Disease | autoimmune hepatitis |
Phenotype | C0023890|cirrhosis |
Sentences | 10 |
PubMedID- 24673965 | Primary diseases were autoimmune hepatitis with liver cirrhosis (n = 2), cystic fibrosis (n = 1), granulomatous liver disease (n = 1) and werlhof disease with liver cirrhosis (n = 1). |
PubMedID- 21042923 | Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: japanese nho-aih prospective study. |
PubMedID- 22234080 | Reversal of liver cirrhosis in autoimmune hepatitis. |
PubMedID- 23879195 | Aim: the aim of this study was to elucidate the clinical and histological features, response to corticosteroid therapy and long-term outcome of primary biliary cirrhosis (pbc) with features of autoimmune hepatitis (aih). |
PubMedID- 24369456 | Combination therapy of ursodeoxycholic acid and corticosteroids for primary biliary cirrhosis with features of autoimmune hepatitis: a meta-analysis. |
PubMedID- 26158166 | Methodology: a 63-year-old woman with hepatic cirrhosis due to autoimmune hepatitis underwent living-donor liver transplantation using a graft donated by her daughter. |
PubMedID- 22693505 | Increased ebv-dna was found in 61% of pbmc, compared to 19% in autoimmune hepatitis, 14% in patients with liver cirrhosis of various causes, and 11% in healthy controls [119]. |
PubMedID- 23359353 | autoimmune hepatitis (aih) can lead to cirrhosis, hepatic failure, and death. |
PubMedID- 25065050 | Primary biliary cirrhosis with autoimmune hepatitis (pcb/aih) overlap is characterized by uncertain behavior and no standardized treatment. |
PubMedID- 22289955 | Liver cirrhosis due to autoimmune hepatitis combined with systemic sclerosis. |
Page: 1